Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3R1M
|
||||
| Drug Name |
2-(4-(3-(p-tolyloxy)propoxy)phenylthio)hexanoic acid
|
||||
| Synonyms |
CHEMBL557342
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H28O4S
|
||||
| Canonical SMILES |
CCCCC(Sc1ccc(OCCCOc2ccc(C)cc2)cc1)C(=O)O
|
||||
| InChI |
InChI=1S/C22H28O4S/c1-3-4-6-21(22(23)24)27-20-13-11-19(12-14-20)26-16-5-15-25-18-9-7-17(2)8-10-18/h7-14,21H,3-6,15-16H2,1-2H3,(H,23,24)
|
||||
| InChIKey |
WMMXNIPBRIKWTB-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
| Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
| PANTHER Pathway | CCKR signaling map ST | ||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.